Venture
Delfi Diagnostics, Inc.
Latest Form D 2025-12-18- CIK 1783735
- State MD
- Biotechnology
- 5 Form D offerings since 2019-08-13
- Total sold
- $366M
- across 5 offerings
- Rounds
- 5
- Form D offerings since 2019-08-13
- Latest round
- $34.3M
- 2025-12-18 · 021-567314
- Investors
- 50
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2025-12-18 · $34.3M
- 2019-08-13$15.3K021-346410
- 2019-08-27$5.5M021-347453
- 2021-01-27$101M021-387477
- 2022-07-25$225M021-453567
- 2025-12-18$34.3M021-567314
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($225M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-567314 | First filed2025-12-18 | Latest2025-12-18 | Sought$60M | Sold$34.3M | Investors50 | Exemptions506(b) |
| 021-453567 | First filed2022-07-25 | Latest2022-07-25 | Sought$225M | Sold$225M | Investors44 | Exemptions506(b) |
| 021-387477 | First filed2021-01-27 | Latest2021-01-27 | Sought$101M | Sold$101M | Investors25 | Exemptions506(b) |
| 021-347453 | First filed2019-08-27 | Latest2019-08-27 | Sought$5.5M | Sold$5.5M | Investors7 | Exemptions506(b) |
| 021-346410 | First filed2019-08-13 | Latest2019-08-13 | Sought$15.3K | Sold$15.3K | Investors9 | Exemptions506(b) |
Who backs Delfi Diagnostics, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-12-18
| Name | Relationship |
|---|---|
| Susan Tousi | RelationshipExecutive Officer, Director |
| Peter B. Bach | RelationshipExecutive Officer |
| Amoolya Singh | RelationshipExecutive Officer |
| Lee-Ann Smith-Freeman | RelationshipExecutive Officer |
| Victor Velculescu | RelationshipDirector |
| Greg Yap | RelationshipDirector |
| Rishi Gupta | RelationshipDirector |
| Michael Dybbs | RelationshipDirector |
| Elizabeth Homans | RelationshipDirector |
| Justin Kao | RelationshipDirector |
| Jacob Van Naarden | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Maryland (MD)
- Exemptions
- Rule 506(b)
- First filed
- 2019-08-13
- Latest filing
- 2025-12-18
Who backs Delfi Diagnostics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗